Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEISTY II: Fibrinogen Concentrate vs Cryoprecipitate in Severe Trauma
NCT05449834Phase 3Completed
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Start
- Nov 2022
- Primary completion
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of Fibrinogen human in psychological trauma, hemorrhagic shock, coagulopathy, sponsored by Australian and New Zealand Intensive Care Research Centre. Started Nov 2022; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
psychological traumahemorrhagic shockcoagulopathy
Beyond the preview
Go deeper on NCT05449834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05449834.